Press release
Clinical Oncology Next Generation Sequencing (NGS) Market Size 2022: Illumina, Roche, Agilent Technologies, Knome, Genomatix Software, GATC Biotech, Oxford Nanopore Technologies, Macrogen
Clinical Oncology Next Generation Sequencing (NGS) Market report performs a study of the Medical Devices industry precisely which explains what the market definition, classifications, applications, engagements, and global industry trends are. This market research report is a great option to make better decisions, generate maximum revenue, and enhance business profit. In this competitive age, comprehensive knowledge about the competitive landscape, the product range of the competitors, strategies, and future prospects are very important. Additionally, this Clinical Oncology Next Generation Sequencing (NGS) Market research report combines historic data, current market trends, market environment, technological innovation, upcoming technologies, and the technical progress in the related industry.Click Here For Free Sample + Related Graphs of the Report at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=5776810
Clinical Oncology Next Generation Sequencing (NGS) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Clinical Oncology Next Generation Sequencing (NGS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Clinical Oncology Next Generation Sequencing (NGS) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Clinical Oncology Next Generation Sequencing (NGS) Market Segment by Type:
NGS Pre-Sequencing
Sequencing
NGS Data Analysis
Primary, Secondary & Tertiary Data Analysis
Clinical Oncology Next Generation Sequencing (NGS) Market Segment by Application:
Academic & Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Clinical Oncology Next Generation Sequencing (NGS) Market By Region:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Clinical Oncology Next Generation Sequencing (NGS) Market By Company:
Illumina
Roche
Agilent Technologies
Knome
Genomatix Software
GATC Biotech
Oxford Nanopore Technologies
Macrogen
Life Technologies
DNASTAR
Exosome Diagnostics
Biomatters
CLC Bio
BGI
Qiagen
Perkin Elmer
Pacific Bioscience
Partek
GnuBIO
Foundation Medicine
Paradigm
Caris Life Sciences
Myriad Genetics
Purchase This Report: https://www.reportsnreports.com/purchase.aspx?name=5776810
Table of Contents
1 Study Coverage
1.1 Clinical Oncology Next Generation Sequencing (NGS) Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Introduction
1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size for the Year 2017-2028
1.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size for the Year 2017-2028
1.3 Clinical Oncology Next Generation Sequencing (NGS) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Clinical Oncology Next Generation Sequencing (NGS) in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Clinical Oncology Next Generation Sequencing (NGS) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Clinical Oncology Next Generation Sequencing (NGS) Market Dynamics
1.4.1 Clinical Oncology Next Generation Sequencing (NGS) Industry Trends
1.4.2 Clinical Oncology Next Generation Sequencing (NGS) Market Drivers
1.4.3 Clinical Oncology Next Generation Sequencing (NGS) Market Challenges
1.4.4 Clinical Oncology Next Generation Sequencing (NGS) Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Clinical Oncology Next Generation Sequencing (NGS) by Type
2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Segment by Type
2.1.1 NGS Pre-Sequencing
2.1.2 Sequencing
2.1.3 NGS Data Analysis
2.1.4 Primary, Secondary & Tertiary Data Analysis
2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2017, 2022 & 2028)
2.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2017-2028)
2.4 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2017, 2022 & 2028)
2.5 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2017-2028)
3 Clinical Oncology Next Generation Sequencing (NGS) by Application
3.1 Clinical Oncology Next Generation Sequencing (NGS) Market Segment by Application
3.1.1 Academic & Clinical Research
3.1.2 Hospitals & Clinics
3.1.3 Pharma & Biotech Entities
3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2017, 2022 & 2028)
3.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2017-2028)
3.4 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2017, 2022 & 2028)
3.5 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2017-2028)
4 Global Clinical Oncology Next Generation Sequencing (NGS) Competitor Landscape by Company
4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Company
4.1.1 Top Global Clinical Oncology Next Generation Sequencing (NGS) Companies Ranked by Revenue (2021)
4.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Player (2017-2022)
4.2 Global Clinical Oncology Next Generation Sequencing (NGS) Concentration Ratio (CR)
4.2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Clinical Oncology Next Generation Sequencing (NGS) in 2021
4.2.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Clinical Oncology Next Generation Sequencing (NGS) Headquarters, Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Type
4.3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Headquarters and Area Served
4.3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Companies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Clinical Oncology Next Generation Sequencing (NGS) Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Company
4.5.1 Top Clinical Oncology Next Generation Sequencing (NGS) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Clinical Oncology Next Generation Sequencing (NGS) Revenue by Players (2020, 2021 & 2022)
5 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region
5.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2017-2028)
5.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region: 2017-2022
5.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth 2017-2028
6.1.2 North America Clinical Oncology Next Generation Sequencing (NGS) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth 2017-2028
6.3.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth 2017-2028
6.4.2 Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
Contact Us:
Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clinical Oncology Next Generation Sequencing (NGS) Market Size 2022: Illumina, Roche, Agilent Technologies, Knome, Genomatix Software, GATC Biotech, Oxford Nanopore Technologies, Macrogen here
News-ID: 2644398 • Views: …
More Releases from ReportsnReports
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Sequencing
Sequencing Reagents Market Report 2024 - Sequencing Reagents Market Trends And S …
"The Business Research Company recently released a comprehensive report on the Global Sequencing Reagents Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Sequencing the Future: Next Generation Sequencing Market Projections (2023-2033)
The global Next-generation Sequencing Market was over 8.5 billion in 2022 and it is anticipated to grow at a CAGR of over 18.2% during the forecast period.
Market Outlook:
The Next Generation Sequencing (NGS) market is set for an extraordinary trajectory of growth and innovation from 2023 to 2033. This decade is poised to witness a paradigm shift in genomics and molecular biology, with NGS technologies playing a central role in reshaping…
Sequencing Reagents Market - Elevating Accuracy, Inspiring Discovery: Revolution …
Newark, New Castle, USA - new report, titled Sequencing Reagents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sequencing Reagents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sequencing Reagents market. The report offers an overview of the market, which…
Microbiome Sequencing Services Market By Technology (Sequencing By Synthesis (SB …
Microbiome are the group of microorganisms that grow on saliva, skin layers, conjunctiva, oral mucosa and the gastrointestinal tract. Microbiome sequencing is the study and analysis of microbes groups located outside and inside of the human body to gain knowledge about human microbes.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00004419/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
Baseclear B.V.
Clinical-Microbiomics A/S
Molzym GmbH & Co. Kg
Zymo Research Corp.
Rancho Biosciences
Microbiome Therapeutics, LLC.
Microbiome Insights Inc.
Openbiome
Resphera Biosciences, LLC.
Ubiome, Inc.
The report covers key developments…
Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com
Get Research Sample PDF at https://www.search4research.com/request-sample/113582/
Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,…
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period.
Metagenomics, is a field where genomic analysis of microbial DNA…
